There has been speculation for many years concerning autoimmune involvement in the pathogenesis of the inflammatory bowel diseases. Is there sufficient evidence to label ulcerative colitis and Crohn's disease as autoimmune disorders?
Definition of autoimmunity Strictly, classification ofa disease as autoimmune requires the demonstration of autoreactive lymphocytes or autoantibodies, or both, which are specific for the disease concerned, present in all cases, and, most important, capable of reproducing the disease on syngeneic transfer. This is not feasible for human disease, where the presence of less exacting criteria are considered suggestive of autoimmune involvement: (a) The second group includes a range of disorders such as autoimmune thyroid disease and systemic lupus erythematosus, many of which have HLA associations primarily with class II gene products. A series of published case reports suggest that members of this group might also be associated with inflammatory bowel disease. There is some support for this contention from population studies,'"" but these studies have been limited either by size or by failure to include an appropriate control group.
A controlled study ofover 1200 patients with inflammatory bowel disease has recently been reported from Oxford'6 documenting the prevalence of a defined range of 'established' autoimmune disorders belonging to this second group. Among the patients with ulcerative colitis, 6-6% had at least one of these disorders, but in contrast, they were no commoner in patients with Crohn's disease (1 9%) than in outpatient controls (2 0%). There was no correlation between the prevalence ofautoimmune disease and the extent of colonic involvement. There was generally no temporal or sequential relation between the onset or activity of ulcerative colitis and the associated autoimmune disorder. This suggests that the association is not causal, but is due rather to a common predisposition to both disorders.
There is increasingly compelling evidence that primary sclerosing cholangitis satisfies the criteria for inclusion in the second group of autoimmune disorders. It 29 Evidence suggests that the HLA B27 associated disorders may arise from immunological cross reactivity between epitopes on Klebsiella nitrogenase and the B27 antigen itself.30 Such a mechanism might be expected to be independent of the cause of enteric inflammation enhancing luminal antigen exposure to the immune system, and would therefore be consistent with the recognised association of B27 related disorders with infective as well as inflammatory enterocolitis. It would also fit well with the association between B27 related disease prevalence and the extent of Crohn's disease of the colon, the major location of commensal bacteria in the gut. The extent to which molecular mimicry with gut luminal antigens is involved in the aetiology of other autoimmune disorders is not known, but recent studies suggest that it may be important in the development of autoimmune thyroiditis3' and primary biliary cirrhosis. 32 Secondly, the environment created by non-specific events causing cellular destruction may render autoantigens expressed by cells in the immediate vicinity immunogenic: Dressler's/postpericardiotomy syndrome3334 is a classical example, but it may also be that some viral infections can induce organ specific autoimmune disease in this way.35 This mechanism may account for the development of autoimmune epiphenomena, such as many of the autoantibodies to colonic epithelium and leucocytes found in patients with inflammatory bowel disease.'"
The final mechanism involves development of an immune response to 'pseudo' autoantigens -that is, acquired cellular antigens which are appropriately recognised by the immune system as foreign. While this mechanism is not strictly autoimmune, it has the potential to generate what appears to be autoimmune disease. Haptenic modification of autoantigens is one way in which this may occur, exemplified by a range of drug induced autoimmune diseases. Another theoretical possibility is cellular expression of viral antigens resulting from unrecognised latent viral infection. It is not known how common this is, but the mounting evidence of viral involvement in the pathogenesis of a range of autoimmune disorders including coeliac disease,3637 chronic active hepatitis,38x Graves' disease,39 and primary sclerosing cholangitis40 suggests that this may be a most important mechanism in the development of (apparent) autoimmune disease. While as yet there is no convincing evidence for viral involvement in the pathogenesis of inflammatory bowel disease, comprehensive tissue examination for latent viral genomic material has not yet been reported.
Conclusion
The inflammatory bowel diseases fulfil some of the criteria required for classification as autoimmune disorders. Substantial differences in the prevalence of associated HLA class II related autoimmune diseases and of certain autoantibodies suggest that autoimmune mechanisms are more likely to be involved in the pathogenesis of ulcerative colitis than of Crohn's disease. The extent of this involvement, however, remains to be determined. Furthermore, implication of autoimmunity in the pathogenesis of ulcerative colitis does not identify the underlying aetiological event.
There are epidemiological and histological grounds for considering that ulcerative colitis and Crohn's disease may form two ends of the same disease spectrum.4' Given a common aetiology, differences in disease expression may perhaps result from differences in the immunological mechanisms involved. The situation may be analogous to that found in leprosy, where the immune response determines whether focal granulomatous ('tuberculoid') or diffuse nongranulomatous ('lepromatous') disease develops in response to the same aetiological agent.4' In contrast to leprosy, however, it might be enhanced autoimmunity rather than deficient xenoimmunity that is responsible for the development of diffuse non-granulomatous disease of the bowelulcerative colitis.
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